FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology and represents using a composition containing sebacic acid and/or its derivatives selected from salts and esters for making a product for oral and enteral introduction which is applicable for: (i) treating or preventing peripheral insulin resistance, impaired glucose tolerance, diabetes, hyperglycemia and related disorders, such as nephropathy, retinopathy, cardiac and cardiovascular diseases (ii) increased glucose clearance and/or insulin responsitivity; (iii) hepatic glucose formation inhibition or (iv) reduced endogenous glucose production.
EFFECT: invention provides regulation and control of the glucose and insulin levels in healthy individuals and diabetic patients.
22 cl, 3 tbl, 5 dwg
